Status
Conditions
About
The aim of this Study is the evaluation of post-infusion CAR-T (Chimeric Antigen Receptor T Cell) expansion and persistence in patients with DLBCL, PMBCL and ALL undergoing CAR-T therapy; and the feasibility and efficacy of the treatment in the real life practice.
Full description
This Study is characterized by several biological sub-studies, reported as below:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Domenico Russo, MD; Mirko Farina, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal